Guard Therapeutics International AB (GUARD) — Capital Reinvestment Ratio

Latest as of March 2015: 2.37x

Guard Therapeutics International AB (GUARD) has a Capital Reinvestment Ratio of 2.37x as of March 2015, meaning it reinvests 2% of its operating cash flow (Skr1.16 Million) in capital expenditures (Skr2.75 Million). See GUARD equity to assets ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

2.37x

Capex / Operating Cash Flow

Operating Cash Flow

Skr1.16 Million

SEK

Capital Expenditures

Skr2.75 Million

SEK

Data as of

Mar 2015

Most recent filing

Annual Capital Reinvestment Ratio for Guard Therapeutics International AB (None–None)

Year-by-year Capital Reinvestment Ratio for Guard Therapeutics International AB from None to None. For live market cap and broader valuation context, see Guard Therapeutics International AB (GUARD) total market value.

Year	Reinvestment Ratio	Operating CF (SEK)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow